Red Velvet’s Irene, Joy, and Yeri were confirmed to be infected with COVID-19. As a result, Red Velvet temporarily delays schedules.
SM Entertainment, announced on the 14th, "Red Velvet Irene, Joy, and Yeri tested positive for COVID-19 self-test kit that was recently preemptively conducted, and received a PCR test, and were finally confirmed last weekend."
Irene, Joy, and Yeri have completed the second dose of COVID-19 vaccination and are currently being treated at home without any symptoms. Seulgi and Wendy were also tested negative in additional tests.
SM Entertainment also added, "As a result, the Red Velvet Special Live 2022 The ReVe Festival: Prologue scheduled for March 19-20 will inevitably be postponed temporarily and tickets will be refunded, and we will review the artist's health and COVID-19 situation."
Despite the confirmation of the members, Red Velvet's new mini-album "The ReVe Festival 2022 - Feel My Rhythm" will be released as scheduled on March 21.
● Official announcement:
Hello, we're SM Entertainment.
Red Velvet's Irene, Joy, and Yeri tested positive for COVID-19 self-test kit, which was recently preemptively conducted, and were finally confirmed last weekend.
Irene, Joy, and Yeri have completed the second dose of COVID-19 vaccination and are currently being treated at home without any symptoms. Seulgi and Wendy were also tested negative in additional tests.
As a result, the Red Velvet Special Live 2022 The ReVe Festival: Prologue, scheduled for March 19-20, will inevitably be postponed temporarily and tickets will be fully paid, and the performance will be decided after reviewing the artist's health and COVID-19 situation.
Also, we would like to inform you that the new Red Velvet mini album "The ReVe Festival 2022 - Feel My Rhythm" will be released as scheduled on March 21.
We will continue to strictly comply with the quarantine guidelines and do our best to focus on treatment and recovery by considering the health and safety of artists as our top priority.
Thank you.
Official announcement via LYSN:
Source: 1